Fibromyalgia and mental health in rheumatoid arthritis: a cross-sectional prevalence study from the COVID-19 pandemic

Objectives This study evaluated the prevalence of fibromyalgia (FM), anxiety and depression in patients with rheumatoid arthritis (RA) and their effects on the clinical parameters of RA during the COVID-19 pandemic. Design Cross-sectional, outpatient clinic, observational, non-interventional. Setting Single-centre, tertiary care, multispecialty, service and research hospital, north-central India. Participants Adult patients with RA, controls. Results This cross-sectional study included 200 patients with RA diagnosed with the American College of Rheumatology/European League Against Rheumatism 2010 (ACR) criteria and 200 controls. FM was diagnosed using the revised 2016 ACR FM Criteria. Disease activity, quality of life and functional disability in patients with RA were assessed using multiple Disease Activity Scores. The presence of depression and anxiety was determined using the Hospital Anxiety and Depression Scale. FM was present in 31% of patients with RA compared with 4% of controls in our study. Patients with RA with FM were older, predominantly females with longer disease duration, and more likely to be on steroids. Patients with RA with FM had a higher disease activity, and none of our RA with FM patients were in remission. The multivariable analysis found FM to be an independent predictor of the Simplified Disease Activity Index for RA. Patients with RA with FM had worse functional ability and poorer quality of life. The prevalence of anxiety and depression was 12.5% and 30%, significantly higher in RA with FM patients. Conclusion During the COVID-19 pandemic, around one-third of our study patients had FM and depression, significantly higher than pre-COVID-19 times. Thus, mental health assessment should be incorporated into the routine management of patients with RA.

[1]  S. Upadhyaya,et al.  AB0281 THE 2016 REVISED ACR FIBROMYALGIA CRITERIA IDENTIFY A HIGHER PREVALENCE OF FIBROMYALGIA IN RHEUMATOID ARTHRITIS PATIENTS: A CROSS-SECTIONAL STUDY FROM INDIA. , 2022, Annals of the Rheumatic Diseases.

[2]  Y. Dal Bosco,et al.  Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis , 2022, International journal of environmental research and public health.

[3]  C. Marshall,et al.  Brain health: The hidden casualty of a humanitarian crisis , 2022, The Lancet regional health. Europe.

[4]  Anil Kumar,et al.  Sleep quality in rheumatoid arthritis , 2022, Indian Journal of Rheumatology.

[5]  S. Norton,et al.  The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritis , 2021, Rheumatology advances in practice.

[6]  S. Tosato,et al.  Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis , 2021, Advances in Rheumatology.

[7]  M. Dougados,et al.  EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis , 2021, Annals of the Rheumatic Diseases.

[8]  S. Upadhyaya,et al.  Validation of Hindi version of the Pittsburg Sleep Quality Index. , 2021, The Journal of the Association of Physicians of India.

[9]  S. Matsuda,et al.  Prevalence of anxiety and depression in patients with rheumatoid arthritis before and during the COVID-19 pandemic. , 2021, Rheumatology.

[10]  B. Haraoui,et al.  Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. , 2020, The New England journal of medicine.

[11]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.

[12]  M. Elshahaly,et al.  Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis , 2019, Rheumatology International.

[13]  G. Littlejohn,et al.  Faculty Opinions recommendation of 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[14]  The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study , 2019, The Journal of Rheumatology.

[15]  F. Wolfe,et al.  Primary and Secondary Fibromyalgia Are The Same: The Universality of Polysymptomatic Distress , 2018, The Journal of Rheumatology.

[16]  N. Goodson,et al.  Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis , 2018, Rheumatology.

[17]  N. Goodson,et al.  309 Comorbid fibromyalgia complicating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and spondyloarthritis: a systematic review and meta-analysis , 2018 .

[18]  T. Huizinga,et al.  Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis , 2018, Annals of the rheumatic diseases.

[19]  F. Salaffi,et al.  The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis , 2017, Rheumatology International.

[20]  H. B. Hammer,et al.  Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study , 2017, Annals of the rheumatic diseases.

[21]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[22]  J. Sturgeon,et al.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways , 2016, Nature Reviews Rheumatology.

[23]  A. Sharabi,et al.  The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study , 2016, The Journal of Rheumatology.

[24]  R. Landewé,et al.  Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs) , 2015, SpringerPlus.

[25]  G. Macfarlane,et al.  The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria , 2015, Arthritis & rheumatology.

[26]  M. Hotopf,et al.  The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis , 2013, Rheumatology.

[27]  H. Boshuizen,et al.  Long‐Term Physical Functioning and Its Association With Somatic Comorbidity and Comorbid Depression in Patients With Established Rheumatoid Arthritis: A Longitudinal Study , 2013, Arthritis care & research.

[28]  Magdalena Cerdá,et al.  PSYCHOPATHOLOGY IN THE AFTERMATH OF THE HAITI EARTHQUAKE: A POPULATION‐BASED STUDY OF POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSION , 2013, Depression and anxiety.

[29]  A. Chopra,et al.  Validation and usefullness of Indian version (CRD Pune) health assessment questionnaire: Drug trials, community practice and COPCORD Bhigwan population study (1994–2012) , 2012 .

[30]  F. Wolfe,et al.  Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia , 2011, The Journal of Rheumatology.

[31]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[32]  J. Fermanian,et al.  Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST) , 2010, PAIN.

[33]  Mahboob Rahman,et al.  Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study , 2010, Annals of the rheumatic diseases.

[34]  F. Wolfe,et al.  The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.

[35]  R. Misra,et al.  Fibromyalgia Is Common and Adversely Affects Pain and Fatigue Perception in North Indian Patients with Rheumatoid Arthritis , 2009, The Journal of Rheumatology.

[36]  M. Bredemeier,et al.  Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[37]  D. M. van der Heijde,et al.  Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial , 2008, Annals of the rheumatic diseases.

[38]  F. Breedveld,et al.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial , 2008, The Lancet.

[39]  M. Uffmann,et al.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score , 2005, Arthritis research & therapy.

[40]  P. Tugwell,et al.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice. , 2003, Rheumatology.

[41]  P. van Riel,et al.  Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. , 1998, Arthritis and rheumatism.

[42]  N. Wig,et al.  Fibromyalgia in Indian patients with SLE , 1998, Lupus.

[43]  M. Power,et al.  Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment , 1998, Psychological Medicine.

[44]  R. Chang,et al.  The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[45]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[46]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[47]  H. B. Hammer,et al.  Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register. , 2019, Clinical and experimental rheumatology.